...
首页> 外文期刊>Malaria Journal >PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs
【24h】

PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs

机译:PfMDR2和PfMDR5可用于恶性疟原虫无性寄生虫繁殖,但改变了体外对抗疟疾药物的敏感性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Membrane-associated ATP binding cassette (ABC) transport proteins hydrolyze ATP in order to translocate a broad spectrum of substrates, from single ions to macromolecules across membranes. In humans, members from this transport family have been linked to drug resistance phenotypes, e.g., tumour resistance by enhanced export of chemotherapeutic agents from cancer cells due to gene amplifications or polymorphisms in multidrug resistance (MDR) protein 1. Similar mechanisms have linked the Plasmodium falciparum PfMDR1 transporter to anti-malarial drug resistance acquisition. In this study, the possible involvement of two related MDR proteins, PfMDR2 and PfMDR5, to emerging drug resistance is investigated by a reverse genetics approach. Methods A homologous double crossover strategy was used to generate P. falciparum parasites lacking the Pfmdr2 (PfΔmdr2) or Pfmdr5 (PfΔmdr5) gene. Plasmodium lactate dehydrogenase activity was used as read-out for sensitivity to artemisinin (ART), atovaquone (ATO), dihydroartemisinin (DHA), chloroquine (CQ), lumefantrine (LUM), mefloquine (MQ), and quinine (QN). Differences in half maximal inhibitory concentration (IC50) values between wild type and each mutant line were determined using a paired t-test. Results Both PfΔmdr2 and PfΔmdr5 clones were capable of asexual multiplication. Upon drug exposure, PfΔmdr2 showed a marginally decreased sensitivity to ATO (IC50 of 1.2 nM to 1.8 nM), MQ (124 nM to 185 nM) and QN (40 nM to 70 nM), as compared to wild type (NF54) parasites. On the other hand, PfΔmdr5 showed slightly increased sensitivity to ART (IC50 of 26 nM to 19 nM). Conclusion Both Pfmdr2 and Pfmdr5 are dispensable for blood stage development while the deletion lines show altered sensitivity profiles to commonly used anti-malarial drugs. The findings show for the first time that next to PfMDR2, the PfMDR5 transport protein could play a role in emerging drug resistance.
机译:背景膜相关的ATP结合盒(ABC)转运蛋白水解ATP,以便跨膜从单个离子到大分子迁移多种底物。在人类中,该转运家族的成员已与耐药性表型相关联,例如,由于基因扩增或多药耐药性(MDR)蛋白1的多态性,增强了化疗药物从癌细胞的输出,从而导致了肿瘤耐药性。恶性疟原虫PfMDR1转运蛋白获得抗疟药耐药性。在这项研究中,通过反向遗传学方法研究了两种相关的MDR蛋白PfMDR2和PfMDR5与新兴耐药性的关系。方法采用同源双交换策略产生缺乏Pfmdr2(PfΔmdr2)或Pfmdr5(PfΔmdr5)基因的恶性疟原虫。乳酸疟原虫脱氢酶活性被用作对青蒿素(ART),阿托伐醌(ATO),二氢青蒿素(DHA),氯喹(CQ),lumantantrine(LUM),甲氟喹(MQ)和奎宁(QN)敏感性的读数。使用配对t检验确定野生型和每个突变株之间的半数最大抑制浓度(IC50)值的差异。结果PfΔmdr2和PfΔmdr5克隆均可无性繁殖。与野生型(NF54)寄生虫相比,药物暴露后,PfΔmdr2对ATO(IC50为1.2 nM至1.8 nM),MQ(124 nM至185 nM)和QN(40 nM至70 nM)的敏感性略有降低。另一方面,PfΔmdr5对ART的敏感性略有提高(IC50为26 nM至19 nM)。结论Pfmdr2和Pfmdr5均可用于血液发育,而缺失系显示出对常用抗疟疾药物敏感性的改变。研究结果首次显示,PfMDR5转运蛋白仅次于PfMDR2,可在新兴耐药性中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号